ArticleBiomolecules2025

Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.

Francesca La Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.